A multi-day intravenous infusion of the local anesthetic lidocaine appears to offer some pain relief to patients battling otherwise untreatable daily migraines. That's the takeaway from a new study ...

ICU A combination of intravenous lidocaine and ketorolac was found to be superior to IV lidocaine alone and comparable with IV ketorolac alone for alleviating suspected renal colic pain. A combination ...

The report explored the use of intravenous lidocaine in a hospital that expanded its use beyond postoperative gastrointestinal surgery. Can the use of postoperative intravenous lidocaine improve pain ...

Lidocaine infusions yield both short- and medium-term pain relief in treatment-resistant chronic migraine, new research suggests. Investigators analyzed data for more than 600 hospitalized patients ...

HONOLULU, HI—A trend towards less pain, functional interference and drowsiness, and improved patient satisfaction exists in patients who received continuous intravenous (IV) lidocaine treatment ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Return of gut function was similar between those ...

Since renal colic pain caused by urinary stones is severe and sudden, an appropriate treatment is of great necessity. Narcotics have been considered as main treatment of renal colic for years; they ...

HealthDay News — For patients with fibromyalgia, use of intravenous lidocaine has no meaningful impact, according to a study published online June 16 in the International Journal of Rheumatic Diseases ...

A woman in pain holding her neck Intravenous, patch lidocaine might be effective in treating, preventing chronic pain. As many as 116 million adults experience chronic pain each year in the United ...

High prevalence of restless legs syndrome in cancer patients undergoing chemotherapy: Relationship with anxiety, depression and quality of life perception No significant financial relationships to ...

A placebo-controlled trial of etanercept, a tumor necrosis factor (TNF) inhibitor, in patients with the cancer anorexia/weight loss syndrome. North Central Cancer Treatment Group (NCCTG) trial N00C1 ...